#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Spinal muscular atrophy Biliary neoplasm Osteosarcoma Stargardt's disease Endometrial adenocarcinoma Mucopolysaccharidosis I Pneumonia Acute lymphocytic leukaemia recurrent Keratosis follicular Rett syndrome Leiomyosarcoma metastatic Glioblastoma multiforme Antiphospholipid syndrome Porphyria non-acute Pleomorphic leiomyosarcoma More trials…

    Learn about Rare Diseases

    Lymphatic malformation – Diagnostics Osteosarcoma metastatic – Diagnostics Wiskott-Aldrich syndrome – Diagnostics Metachromatic leukodystrophy – Diagnostics Hereditary angioedema Ocular melanoma – Trials in Disease Alexander disease – Trials in Disease Sarcoma Ehlers-Danlos syndrome – Treatment Progressive multifocal leukoencephalopathy – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Betamethasone Lomustine Olanzapine LUMC-BOB1-B7-TCR.1 Navitoclax THEOPHYLLINE ANHYDROUS Recombinant Interferon Beta-1B Chlorphenamine Maleate Pd01B Clodronate Disodium Tranexamic Acid Colistimethate Sodium L-Acetylleucine Ocrelizumab Interleukin-2 Mk-0616 VELPATASVIR Sulfonamides, Urea Derivatives Bisoprolol Fumarate CYCLIZINE HYDROCHLORIDE More therapies…

    Learn about Your Condition

    Hypotension Vomiting Progressive multiple sclerosis Von Willebrand's disease Endometrial cancer stage III Familial hypertriglyceridaemia Kidney transplant rejection Hypersomnia Weaning failure Diabetic retinal oedema Dementia Deep vein thrombosis Pruritus Type V hyperlipidaemia Urinary incontinence More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Universitetssykehuset Nord-Norge HF

Universitetssykehuset Nord-Norge HF

P. O. Box 100, Tromsø, 9038, Norway

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma stage II
    • Mantle cell lymphoma stage III
    • Mantle cell lymphoma stage IV
    Investigated Drugs:
    • Ibrutinib
    Belgium Czechia Denmark Finland Germany Italy +6

  • Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Asundexian
    • Apixaban
    Austria Belgium Bulgaria Czechia Denmark Estonia +16

  • Study on Monkeypox Virus Disease: Effects of Tecovirimat in Patients with and without Antiviral Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Monkeypox
    Investigated Drugs:
    • Tecovirimat
    Belgium France Ireland Italy The Netherlands Norway +2

  • Study on MK-2870 for Patients with Endometrial Cancer After Platinum and Immunotherapy Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Caffeine
    • Acetylsalicylic Acid
    • Doxorubicin
    Austria Belgium Czechia Denmark Finland France +9
Previous Page
1 … 11 12 13

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!